proactive gene testing

Patients

Genetic testing update with 23andMe’s Noura Abul-Husn

In the latest instalment of the pharmaphorum podcast, editor-in-chief Jonah Comstock is joined by Dr Noura Abul-Husn, VP of genomic health at 23andMe.

News

Ipsen charts $1.75bn course for Kartos acquisition

Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks